Pharming (PHAR) Common Equity (2019 - 2026)
Pharming's Common Equity came in at $270.49 million for Q2 2026, up 12.9% from $239.55 million a year earlier and up 0.6% from the prior quarter.
Powered by 
Analysis
Pharming (PHAR) Common Equity (2019 - 2026) Analysis & Trends
At the end of FY2025, Pharming's Common Equity was $277.1 million, up 25.4% from FY2024.
- Common Equity has increased in each of the last six years, with a five-year compound annual growth rate of 8.6% (FY2020 to FY2025).
- Going back by year, Common Equity was $221.06 million in FY2024 (+1.0%), $218.78 million in FY2023 (+6.9%), $204.64 million in FY2022 (+6.1%) and $192.92 million in FY2021 (+5.2%).
- The five-year range for quarterly Common Equity is $194,716 (Q4 2021) to $277.1 million (Q4 2025).
- Year-over-year, Common Equity has increased for 11 consecutive quarters, with growth averaging 12.7% over the last eight quarters.
- The fastest year-over-year change in Common Equity over five years came in Q4 2025 (growth of 25.4%), and the weakest in Q3 2022 (a decline of 99.9%).
- Business Quant data shows PHAR's Common Equity at $268.96 million (Q1 2026), $277.1 million (Q4 2025) and $264.64 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 41.98 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 50.37 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 11.69 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 11.83 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 85.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 20.25 Bn |
| 10 | Pharming | 738.17 Mn | -91.99 Mn | 141.47 Mn | 270.49 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 270.49 Mn |
| Mar 31, 2026 | 268.96 Mn |
| Dec 31, 2025 | 277.10 Mn |
| Sep 30, 2025 | 264.64 Mn |
| Jun 30, 2025 | 239.55 Mn |
| Mar 31, 2025 | 215.29 Mn |
| Dec 31, 2024 | 221.06 Mn |
| Sep 30, 2024 | 225.79 Mn |
| Jun 30, 2024 | 220.94 Mn |
| Mar 31, 2024 | 205.95 Mn |
| Dec 31, 2023 | 218.78 Mn |
| Sep 30, 2023 | 209.94 Mn |
| Jun 30, 2023 | 200.37 Mn |
| Mar 31, 2023 | 199.34 Mn |
| Dec 31, 2022 | 204.64 Mn |
| Sep 30, 2022 | 200,254.00 |
| Jun 30, 2022 | 199.67 Mn |
| Mar 31, 2022 | 194.02 Mn |
| Dec 31, 2021 | 194,716.44 |
| Sep 30, 2021 | 193.55 Mn |
API Access
Pharming Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=PHAR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "PHAR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=PHAR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();